Michael-Alexander Malahias1, Seong J Jang2, Alex Gu1,3, Shawn S Richardson4, Aaron Z Chen2, Raj D Rao3, Peter K Sculco5. 1. Complex Joint Reconstruction Center, Department of Orthopedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY, 10021, USA. 2. Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. 3. Department of Orthopedic Surgery, George Washington School of Medicine and Health Sciences, 2300 M St NW, Washington, DC, 20037, USA. 4. Department of Orthopedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY, 10021, USA. 5. Complex Joint Reconstruction Center, Department of Orthopedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY, 10021, USA. sculcop@hss.edu.
Abstract
INTRODUCTION: The relationship between cervical degenerative pathology and total knee arthroplasty (TKA) revision rates is not well understood. The aim of the study was to determine whether cervical spine degenerative diseases have a role in complications following TKA within 2 years. METHODS: Data were collected from the Humana insurance database using the PearlDiver Patient Records Database from 2007-2017. Patients who had a primary TKA were identified using Current Procedural Terminology (CPT) code 27,447, and patients with degenerative cervical disease were identified using CPT and International Classification of Diseases (ICD) codes. Data on patients' demographics, comorbidities and postoperative complications were recorded and analyzed with univariate and multivariate analysis with significance set at p < 0.05. A Kaplan-Meier analysis was conducted to estimate the 1- and 2-year rates of survival free from revision. RESULTS: A total of 81,873 patients were included in this study. Following multivariate analysis, cervical spine degenerative disease patients were at increased risk of all-cause revision surgery following 1 year (OR: 1.342 95% CI: 1.149-1.569; p < 0.001) and 2 year (OR: 1.338; 95% CI: 1.184-1.512; p < 0.001). At 2 years, patients with cervical spine degenerative disease had a survival rate of 97.7%, while the survival rate was 99.2% among the non-cervical degenerative cohort. CONCLUSIONS: Based on these results, patients with cervical spine degenerative pathology should be counseled that their spinal pathology may impair outcomes following TKA.
INTRODUCTION: The relationship between cervical degenerative pathology and total knee arthroplasty (TKA) revision rates is not well understood. The aim of the study was to determine whether cervical spine degenerative diseases have a role in complications following TKA within 2 years. METHODS: Data were collected from the Humana insurance database using the PearlDiver Patient Records Database from 2007-2017. Patients who had a primary TKA were identified using Current Procedural Terminology (CPT) code 27,447, and patients with degenerative cervical disease were identified using CPT and International Classification of Diseases (ICD) codes. Data on patients' demographics, comorbidities and postoperative complications were recorded and analyzed with univariate and multivariate analysis with significance set at p < 0.05. A Kaplan-Meier analysis was conducted to estimate the 1- and 2-year rates of survival free from revision. RESULTS: A total of 81,873 patients were included in this study. Following multivariate analysis, cervical spine degenerative diseasepatients were at increased risk of all-cause revision surgery following 1 year (OR: 1.342 95% CI: 1.149-1.569; p < 0.001) and 2 year (OR: 1.338; 95% CI: 1.184-1.512; p < 0.001). At 2 years, patients with cervical spine degenerative disease had a survival rate of 97.7%, while the survival rate was 99.2% among the non-cervical degenerative cohort. CONCLUSIONS: Based on these results, patients with cervical spine degenerative pathology should be counseled that their spinal pathology may impair outcomes following TKA.
Entities:
Keywords:
Cervical degenerative disease; Revision rates; Total knee arthroplasty
Authors: Andrew J Carr; Otto Robertsson; Stephen Graves; Andrew J Price; Nigel K Arden; Andrew Judge; David J Beard Journal: Lancet Date: 2012-03-06 Impact factor: 79.321
Authors: Jordan S Cohen; Alex Gu; Nisha Kapani; Paul A Asadourian; Seth Stake; Theodore Quan; Michael A Malahias; Peter K Sculco Journal: J Knee Surg Date: 2020-04-30 Impact factor: 2.757
Authors: Andrew J Price; Abtin Alvand; Anders Troelsen; Jeffrey N Katz; Gary Hooper; Alastair Gray; Andrew Carr; David Beard Journal: Lancet Date: 2018-11-03 Impact factor: 79.321
Authors: Mohammed F Shamji; Christopher P Ames; Justin S Smith; John M Rhee; Jens R Chapman; Michael G Fehlings Journal: Spine (Phila Pa 1976) Date: 2013-10-15 Impact factor: 3.468